ATE29875T1 - Allylamin-mao-inhibitoren. - Google Patents

Allylamin-mao-inhibitoren.

Info

Publication number
ATE29875T1
ATE29875T1 AT82400991T AT82400991T ATE29875T1 AT E29875 T1 ATE29875 T1 AT E29875T1 AT 82400991 T AT82400991 T AT 82400991T AT 82400991 T AT82400991 T AT 82400991T AT E29875 T1 ATE29875 T1 AT E29875T1
Authority
AT
Austria
Prior art keywords
sub
integer
hydrogen
formula
phenyl
Prior art date
Application number
AT82400991T
Other languages
English (en)
Inventor
Philippe Bey
Original Assignee
Merrell Dow France
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow France filed Critical Merrell Dow France
Application granted granted Critical
Publication of ATE29875T1 publication Critical patent/ATE29875T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C209/00Preparation of compounds containing amino groups bound to a carbon skeleton
    • C07C209/62Preparation of compounds containing amino groups bound to a carbon skeleton by cleaving carbon-to-nitrogen, sulfur-to-nitrogen, or phosphorus-to-nitrogen bonds, e.g. hydrolysis of amides, N-dealkylation of amines or quaternary ammonium compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44Iso-indoles; Hydrogenated iso-indoles
    • C07D209/48Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/26Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C29/00Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
    • C07C29/132Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group
    • C07C29/136Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group of >C=O containing groups, e.g. —COOH
    • C07C29/147Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group of >C=O containing groups, e.g. —COOH of carboxylic acids or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C33/00Unsaturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
    • C07C33/40Halogenated unsaturated alcohols
    • C07C33/46Halogenated unsaturated alcohols containing only six-membered aromatic rings as cyclic parts
    • C07C33/48Halogenated unsaturated alcohols containing only six-membered aromatic rings as cyclic parts with unsaturation outside the aromatic rings
    • C07C33/483Monocyclic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C33/00Unsaturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
    • C07C33/40Halogenated unsaturated alcohols
    • C07C33/46Halogenated unsaturated alcohols containing only six-membered aromatic rings as cyclic parts
    • C07C33/48Halogenated unsaturated alcohols containing only six-membered aromatic rings as cyclic parts with unsaturation outside the aromatic rings
    • C07C33/486Polycyclic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00Ethers; Compounds having groups, groups or groups
    • C07C43/02Ethers
    • C07C43/20Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
    • C07C43/225Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring containing halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00Ethers; Compounds having groups, groups or groups
    • C07C43/02Ethers
    • C07C43/20Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
    • C07C43/23Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring containing hydroxy or O-metal groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/09Geometrical isomers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Furan Compounds (AREA)
  • Indole Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Treatment Of Sludge (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Purification Treatments By Anaerobic Or Anaerobic And Aerobic Bacteria Or Animals (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pretreatment Of Seeds And Plants (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
AT82400991T 1981-06-01 1982-05-27 Allylamin-mao-inhibitoren. ATE29875T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/268,555 US4454158A (en) 1981-06-01 1981-06-01 Allyl amine MAO inhibitors
EP82400991A EP0067105B1 (de) 1981-06-01 1982-05-27 Allylamin-MAO-inhibitoren

Publications (1)

Publication Number Publication Date
ATE29875T1 true ATE29875T1 (de) 1987-10-15

Family

ID=23023513

Family Applications (1)

Application Number Title Priority Date Filing Date
AT82400991T ATE29875T1 (de) 1981-06-01 1982-05-27 Allylamin-mao-inhibitoren.

Country Status (18)

Country Link
US (1) US4454158A (de)
EP (1) EP0067105B1 (de)
JP (1) JPS5823649A (de)
KR (1) KR890002756B1 (de)
AT (1) ATE29875T1 (de)
AU (2) AU550607B2 (de)
CA (2) CA1187500A (de)
DE (1) DE3277371D1 (de)
DK (1) DK244282A (de)
ES (4) ES512699A0 (de)
GB (2) GB2100255B (de)
GR (1) GR78033B (de)
IE (1) IE53456B1 (de)
IL (2) IL65808A (de)
MX (1) MX9202950A (de)
NO (1) NO152837C (de)
NZ (1) NZ200644A (de)
ZA (1) ZA823633B (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4699928A (en) * 1984-07-13 1987-10-13 Merrell Dow Pharmaceuticals Inc. Fluoroallylamine derivatives
NZ214697A (en) * 1984-12-31 1988-10-28 Merrell Dow Pharma B-methylene-2- and 3-furanethanamine and pharmaceutical compositions
US4703058A (en) * 1984-12-31 1987-10-27 Merrell Dow Pharmaceuticals Inc. β-methylene furanethanamines and use as anti-hypertensive agents
NZ214698A (en) * 1984-12-31 1988-08-30 Merrell Dow Pharma Thiophene derivatives and pharmaceutical compositions containing such
US4650907A (en) * 1985-12-05 1987-03-17 Merrell Dow Pharmaceuticals Inc. Nonaromatic fluoroallylamine MAO inhibitors
ATE71933T1 (de) * 1985-12-05 1992-02-15 Merrell Dow Pharma Nichtaromatische fluoralkylamin-mao-inhibitoren.
US4822812A (en) * 1987-05-21 1989-04-18 Merrell Dow Pharmaceuticals Inc. β-(Fluoromethylene)-5-hydroxytryptophan and derivatives and their use as prodrugs for MAO inhibition
CA1335897C (en) * 1987-06-16 1995-06-13 Ian A. Mcdonald (e)-2-(p-fluorophenethyl)-3-fluoroallylamine
US5059714A (en) * 1988-02-25 1991-10-22 Merrell Dow Pharmaceuticals Inc. Inhibitors of lysyl oxidase
US5182297A (en) * 1988-02-25 1993-01-26 Merrell Dow Pharmaceuticals Inc. Inhibitors of lysyl oxidase
NZ228068A (en) * 1988-02-25 1991-11-26 Merrell Dow Pharma Brominated or chlorinated allylamines and their pharmaceutical compositions
US5252608A (en) * 1988-02-25 1993-10-12 Merrell Dow Pharmaceuticals Inc. Inhibitors of lysyl oxidase
US4943593A (en) * 1988-02-25 1990-07-24 Merrell Dow Pharmaceuticals Inc. Inhibitors of lysyl oxidase
US4965288A (en) * 1988-02-25 1990-10-23 Merrell Dow Pharmaceuticals Inc. Inhibitors of lysyl oxidase
US5120764A (en) * 1988-11-01 1992-06-09 Merrell Dow Pharmaceuticals Inc. Inhibitors of lysyl oxidase
US4981868A (en) * 1989-07-25 1991-01-01 Merrell Dow Pharmaceutical Pharmaceutically active 3-heteroaryl-2-fluoro-1-olefins
TR199700878T1 (xx) * 1995-03-02 1998-01-21 R.P. Scherer Limited Monamin oksidaz B inhibit�rleri i�eren farmakotik kompozisyonlar.
US20070293548A1 (en) * 2006-03-31 2007-12-20 Wang Eric Y Inhibitors of semicarbazide-sensitive amine oxidase (SSAO) and VAP-1 mediated adhesion useful for treatment and prevention of diseases
BRPI0713944A2 (pt) * 2006-07-13 2012-12-04 Basf Se compostos, processo para preparar compostos, composição, semente e, processo para combater fungos nocivos fitopatogênicos
WO2009055002A1 (en) * 2007-10-24 2009-04-30 La Jolla Pharmaceutical Company Combined inhibitors of cyclooxygenase and semicarbazide-sensitive amine oxidase (ssao) (vascular adhesion protein, vap-1)
CN101917845A (zh) 2007-11-21 2010-12-15 法马克西斯制药公司 Ssao/vap-1的卤代烯丙胺抑制剂及其用途
RS57086B1 (sr) 2012-05-02 2018-06-29 Boehringer Ingelheim Int Supstituisani 3-haloalilamin inhibitori ssao i njihova primena
WO2015087094A1 (en) * 2013-12-10 2015-06-18 Semmelweis Egyetem New arylalkenylpropargylamine derivatives exhibiting neuroprotective action for the treatment of neurodegenerative diseases
AR115906A1 (es) 2018-08-03 2021-03-10 Pharmaxis Ltd Derivados de haloalilamina sulfona como inhibidores de lisil oxidasas

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2343038A1 (de) * 1973-08-25 1975-03-06 Hoechst Ag 2,3-diaryl-3-halogenallylamine und verfahren zu ihrer herstellung
SE7809127L (sv) * 1978-08-30 1980-03-01 Claesson Alf Allenaminer

Also Published As

Publication number Publication date
ES8503638A1 (es) 1985-04-16
MX9202950A (es) 1992-07-01
DK244282A (da) 1982-12-02
US4454158B1 (de) 1992-12-22
NO152837B (no) 1985-08-19
ES8503639A1 (es) 1985-04-16
IL65808A (en) 1986-12-31
EP0067105B1 (de) 1987-09-23
NO821799L (no) 1982-12-02
KR830010044A (ko) 1983-12-24
GB8428858D0 (en) 1984-12-27
GB2100255B (en) 1985-10-23
NO152837C (no) 1985-11-27
JPH0422898B2 (de) 1992-04-20
US4454158A (en) 1984-06-12
EP0067105A3 (en) 1984-02-22
IL65808A0 (en) 1982-08-31
IE53456B1 (en) 1988-11-23
IE821246L (en) 1982-12-01
GB2152039B (en) 1986-04-30
ES523874A0 (es) 1985-04-16
AU550607B2 (en) 1986-03-27
AU8423882A (en) 1983-02-03
ES523875A0 (es) 1985-04-16
CA1204759A (en) 1986-05-20
CA1187500A (en) 1985-05-21
KR890002756B1 (ko) 1989-07-27
DE3277371D1 (en) 1987-10-29
ES523873A0 (es) 1985-10-01
GB2152039A (en) 1985-07-31
EP0067105A2 (de) 1982-12-15
JPS5823649A (ja) 1983-02-12
ES8402810A1 (es) 1984-03-01
AU5180586A (en) 1986-06-12
GB2100255A (en) 1982-12-22
ZA823633B (en) 1983-03-30
AU576281B2 (en) 1988-08-18
NZ200644A (en) 1986-06-11
GR78033B (de) 1984-09-26
ES8507461A1 (es) 1985-10-01
IL75829A0 (en) 1985-11-29
ES512699A0 (es) 1984-03-01

Similar Documents

Publication Publication Date Title
US4454158B1 (de)
KR900007406A (ko) 리실 옥시마제의 억제제
ES2000842A6 (es) Un procedimiento para la preparacion de analogos semisinteticos de compactina y mevinolina
NO812311L (no) Bronchospasmolytisk virksomme forbindelser og fremgangsmaate for deres fremstilling
DK1089998T3 (da) Epothilon-derivater samt deres syntese og anvendelse
ATE215925T1 (de) Aryl- oder heteroaryl-substituierte 3,4- dihydroanthracene sowie aryl- oder heteroaryl- substituierte benzo(1,2g)-chrom-3-en-, benzo(1, 2g)-thiochrom-3-en- und benzo(1,2g)-1,2- dihydrochinolin-derivate mit retinoid antagonistischer oder invers antagonistischer aktivität
NO921719L (no) Fosfono/biaryl-substituerte dipeptidderivater
RU94045271A (ru) Применение 2-фенил-3-ароилбензотиофенов для ингибирования синдрома тернера
ES420292A1 (es) Procedimiento para preparar carbamatos n-sulfenilados.
FI934680A (fi) Arylmorfolin, framstaellning och anvaending
ES485043A1 (es) Procedimiento para la preparacion de nuevas 2-fenilimino- imidazolidinas sustituidas
KR890012641A (ko) 리실 옥시다제의 억제제
FI955680A (fi) Psoraleenijohdannaiset, niiden valmistus ja käyttö
EP0218195A3 (de) Bis-(Dibenzo[b,d]pyranyloxy)-propane
JPS6442043A (en) Magneto-optical recording medium